Shandong Wohua Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Shandong Wohua Pharmaceutical Technology Co., Ltd. (hereinafter referred to as Wohua Pharmaceutical) was founded in 2003 and is affiliated with Beijing Zhongzheng Wanrong Investment Group Co., Ltd. It is located in Weifang, Shandong, the hometown of Confucius and Mencius and the world's kite capital. Its history can be traced back to the Wanhetang Pharmacy during the Qianlong period of the Qing Dynasty. In 2007, new shares were publicly issued and listed on the Shenzhen Stock Exchange (stock code: 002107). In 2015, the acquisition of Jiangxi Wohua Jishun Pharmaceutical Co., Ltd. (formerly known as Nanchang Jishun Pharmaceutical Co., Ltd.) and Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. opened up a healthy landscape of "resource sharing and collaborative efficiency enhancement"! Its subsidiary, Jiangxi Wohua Jishun Pharmaceutical Co., Ltd., was established in 2000 and is located in Sanghai Industrial Park, Ganjiang New District, Nanchang City. It is a modern pharmaceutical enterprise that integrates scientific research, development, production, and sales, and is a high-tech enterprise. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. was established in 2002 and is located in Qianyang Town, Donggang City, Dandong City, China. It is a modern traditional Chinese medicine pharmaceutical enterprise with first-class production and quality control equipment, and is a high-tech enterprise. Wohua Pharmaceutical has 40 national invention patents and 162 drug approval numbers, including 15 exclusive products. 93 products have been included in the "National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug Catalogue (2021 Edition)", and 43 products have been included in the "National Basic Drug Catalogue (2018 Edition)"; We are a high-tech enterprise with research platforms such as provincial-level enterprise technology centers, provincial-level engineering technology research centers, and provincial-level key laboratories. Wohua Pharmaceuticals, with its unique corporate culture and exclusive product line as two unique swords, adheres to the concept of governing the enterprise, adheres to the core mission of "creating excellent value for human health", practices the core values of "customer first, serving others, integrity, and innovation", persists in focus, and strives to forge ahead; We will spare no effort to build four exclusive medical insurance pillar products, namely, Xinkeshu Tablets, Gushukang Capsules/Granules, Hedan Tablets/Capsules, and Naoxueshu Oral Liquid. Through point to area, resource sharing, and synergy, we will drive the sales of other exclusive products of the company and traditional traditional Chinese patent medicines and simple preparations. Through independent research and development, joint research and development, and investment and acquisition, we will build the first brand in the field of exclusive products, and strive to become a respected modern enterprise with the most exclusive products!. |
| Headquarter | Weifang |
| Establish Date | 2/9/2002 |
| Listed Code | 002107.SZ |
| Listed Date | 1/24/2007 |
| Chairman | Zhao Bingxian. |
| CEO | Zeng Yingzi. |
| Website | www.wohua.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
